NexImmune, Inc. (NEXI)

USD 0.23

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue 1.02 Million 1.49 Million 870.28 Thousand 618.99 Thousand 436.36 Thousand 204.64 Thousand
Gross Profit -1.02 Million -1.49 Million -870.28 Thousand -618.99 Thousand -436.36 Thousand -204.64 Thousand
Operating Expenses 28.16 Million 63.08 Million 53.25 Million 27.85 Million 20.88 Million 13.24 Million
Selling, General and Administrative Expenses 9.91 Million 15.93 Million 15.79 Million 10.01 Million 5.71 Million 5.24 Million
Research and Development Expenses 18.25 Million 47.14 Million 37.45 Million 17.83 Million 15.17 Million 7.99 Million
Other Expenses - -87.68 Thousand -61.4 Thousand 89.77 Thousand 92.27 Thousand 136.78 Thousand
Cost and Expenses 29.19 Million 63.08 Million 53.25 Million 27.85 Million 20.88 Million 13.24 Million
Operating Income -29.19 Million -63.08 Million -53.25 Million -27.85 Million -20.88 Million -13.24 Million
Interest Expense - - 905.32 Thousand 1.68 Million - -
Income Tax Expense -2.00 -576.69 Million 843.91 Thousand 1.77 Million -246.78 Thousand 409.22 Thousand
Earnings before Tax -32.34 Million -62.5 Million -50.9 Million -29.86 Million -20.54 Million -12.83 Million
Net Income -32.34 Million 514.18 Million -51.74 Million -31.63 Million -20.29 Million -12.83 Million
Earnings Per Share Basic -30.82 534.29 -56.67 -34.76 -22.53 -14.25
Earnings Per Share Diluted -30.82 534.29 -56.67 -34.76 -22.53 -14.25
Weighted Average Shares Outstanding 1.04 Million 962.36 Thousand 913.15 Thousand 910.31 Thousand 900.86 Thousand 900.86 Thousand
Weighted Average Shares Outstanding (Diluted) 1.04 Million 962.36 Thousand 913.15 Thousand 910.31 Thousand 900.86 Thousand 900.86 Thousand
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -28.16 Million -61.58 Million -52.39 Million -27.12 Million -20.44 Million -13.03 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts